ACCESS Annual Meeting - Networking Poster Sessions

The Networking Poster Sessions demonstrate the breadth of ACCESS-supported projects and initiatives that address complex challenges through coordinated, multi-faceted approaches.

These sessions will allow the ACCESS network to see how the collaborative approach to science connects within the broader childhood cancer ecosystem and an opportunity to engage directly with the project teams behind it.

Unpublished data has been redacted in some posters below.

Comprehensive Care (Posters 1 – 8)

 

#1 Making Caregiver Distress Visible: Pre-implementation of Digital Psychosocial Screening in Pediatric Oncology

#2 Count Every Kilometre: The Hidden Impact of Travelling for Pediatric Cancer Treatment in Canada

#3 Development of the Fear of Cancer Recurrence Therapy Intervention for Adolescent and Early Young Adult Survivors of Childhood Cancer (FORT-AeYA): Adaptation and Usability Study

#4 Access to Approved Therapies: Public Listing of Drugs with Pediatric and Adolescent Indications

#5 Screening for Patient Distress in Pediatric Cancer Care: A Recommendation from the Pan-Canadian ACCESS (Advancing Childhood Cancer Experience, Science and Survivorship) Network

#7 Exploring the Lived Experiences of Adult Survivors of Childhood Cancer with Chronic Pain: A Qualitative Examination

#8 DECRYPT-BABYBRAIN Clinical Trial: A pilot study of intrathecal topotecan and maintenance chemotherapy in the post-consolidation setting for the treatment of high-risk embryonal central nervous system tumours in children less than 6 years of age

 

Access to Innovation (Posters 9 – 16)

 

#9 A cross-sectional study of childhood cancers treated with proton radiation therapy in Canada

#10 A National Expansion of the STEP-1 Pilot Initiative – Supporting Travel for Pediatric and Adolescent Patients to Access Academic Phase I/II Trials in Canada

#11 National Molecular Pathology Strategy

#12 OPTIMISE: Optimal Precision Therapies to Customise Care in Childhood and Adolescent Cancer

#13 MIRV: A Phase I/II Study of Mirdametinib and Vinblastine for Newly Diagnosed Patients with Pediatric Low-Grade Glioma and Activation of the MAPK Pathway

#14 VICTORY: A Pilot Study to Investigate Safety and Efficacy of Weekly Combination of Intravenous Vinblastine with Oral Type II RAF Inhibitor Tovorafenib in Pediatric Patients with Recurrent/Progressive RAF-Altered (non-NF1) Low Grade Gliomas

#15 AALL2131: An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitor with Blinatumomab in Patients with Newly-Diagnosed Philadelphia Chromosome Positive or ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia

#16 Understanding access to high-cost novel cancer therapies across Canada: a survey of pediatric oncology providers

 

Systems & Policy (Posters 17 – 23)

 

#17 Real world testing and evaluation of the Comprehensive Assessment of Technologies for Child Health (CATCH) Framework

#18 Factors impacting treatment decision-making in pediatric oncology: a discrete choice experiment

#19 The National Pediatric Oncology Drug Access Navigator (DAN-PO)

#20 Research for action on social, intersectional and geographical disparities in economic outcomes for families impacted by pediatric cancer

#21 Leveraging Human Rights to Clarify the Risk of Genetic Discrimination in Pediatric Oncology

#22 Canadian Pediatric Oncology Innovation Sandbox | Project#1: Accelerated Regulatory and Reimbursement Approval

#23 Investigating the Impacts of Generative AI in Pediatric Oncology: Identifying Ethico-Legal Best Practices and Addressing Patient Community Concerns

 

Pan-Canadian Networks & Research Resources (Posters 24 – 33)

 

#24 Pan-Canadian Approaches to Data Sharing & Access

#25 Proton and Photon Consortium Registry (PPCR) – Enabling Canadian Participation

#26 Development of a Canadian Pediatric CAR T-Cell Network

#27 Clinical Trials Incubator

#28 A National Pediatric Preclinical Modelling Program to Advance Precision Oncology for Childhood Cancers in Canada

#29 Multimodal Profiling to Identify Therapeutic Targets Preventing Metastasis and Relapse in High-Risk Pediatric Sarcomas: A Sarcoma MetAstasis Research Taskforce (SMART) Study

#30 Advancing Inclusive Youth-Led Research in Pediatric Cancer: A Participatory Action Research Project

#31 ACCESS National Biobanking Project

#32 Needs Assessment Survey: Determining Biobanking Needs to Further Pediatric, Adolescent and Young Adult Cancer Research

#33 Pediatric Cancer Models and Mechanisms Network

 

Capacity Building & Inclusion (Posters 34 – 38 and 57 – 58)

 

#34 Collaborative Creation and Curation of In-Progress Child-Centric Knowledge Mobilization Exemplars, Processes and Products

#35 ACCESS Presents: A Webinar Series

#36 ACCESS Summer Student Research Program

#37 Knowledge Mobilization Needs Assessment of the Childhood Cancer Community in Canada

#38 The First Eureka Translational Medicine Certificate Course for Cancers in Children and Young Adults

#57 Transforming Clinical Trial Capacity in Canada: Implementation of National Infrastructure for NCC, IIT and Risk-Based Monitoring

#58 Canadian Cancer Research Conference: Community-Engaged Discussion

 

Patient/Family Empowerment (Posters 39 – 45)

 

#39 The ACCESS Book Club: Empowering the Pediatric Cancer Community Through Literature

#40 ACCESS Special Collection of Frontiers for Young Minds

#41 Beyond the Binder: Tools for the Journey, Not the Shelf – Innovative and Integrative Family-Centred Navigation Resources

#42 Persons With Lived Experience (PWLE) Travel Subsidy

#44 Advancing the Well-Being of Childhood Cancer Survivors – Bringing the Passport for Care to Ontario

#45 Understanding the Current Landscape of Survivorship Care for Childhood, Adolescent, and Young Adult Survivors of Childhood Cancers and Developing a Canadian Survivorship Care and Advocacy Network

 

Understanding of Pediatric Cancer (Posters 46 – 54)

 

#46 Development of a novel orthotopic brain tumor murine model for pre-clinical evaluation of CAR T cells

#47 Patient-derived organoids (PDOs) to model nephroblastoma (Wilms tumour)

#48 Reducing Planning Target Volume Margins in Paediatric Radiotherapy

#49 Organoid-Based Precision Medicine for Cancer Treatment

#50 Diagnostic and precision intervention for leukemia arising in infancy

#51 Serial analysis of CSF ctDNA in metastatic mouse models of medulloblastoma to monitor metastasis evolution

#52 Deciphering 3D Chromatin States Permissive to Driver Alterations in High-Grade Childhood Brain Tumors

#53 Reclassifying DNMT3A VUS variants from Tatton-Brown-Rahman Syndrome-Associated Leukemias in Drosophila assays

#54 Expanding the use of patient-derived organoids to guide personalized treatment in pediatric cancers: a pilot study